-
EP3463383
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3463383
| EP3463383 - DIRECT REPROGRAMMING OF A HUMAN SOMATIC CELL TO A SELECTED (PREDETERMINED) DIFFERENTIATED CELL WITH FUNCTIONALIZED NANOPARTICLES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 04.06.2021 Database last updated on 22.08.2024 | |
| Former | Request for examination was made Status updated on 08.03.2019 | ||
| Former | The international publication has been made Status updated on 08.12.2017 | Most recent event Tooltip | 06.08.2024 | New entry: Additional fee for renewal fee: despatch of communication + time limit | Applicant(s) | For all designated states Stemgenics, Inc. 454 N 34th Street Seattle, WA 98103 / US | [2019/15] | Inventor(s) | 01 /
APRIKYAN, Andranik Andrew 454 N. 34th Street Seattle WA 98103 / US | [2019/15] | Representative(s) | MacLean, Martin Robert Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
| Former [2019/15] | MacLean, Martin Robert Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 17807622.0 | 02.06.2017 | [2019/15] | WO2017US35823 | Priority number, date | US201662345360P | 03.06.2016 Original published format: US 201662345360 P | [2019/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017210638 | Date: | 07.12.2017 | Language: | EN | [2017/49] | Type: | A1 Application with search report | No.: | EP3463383 | Date: | 10.04.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.12.2017 takes the place of the publication of the European patent application. | [2019/15] | Search report(s) | International search report - published on: | US | 07.12.2017 | (Supplementary) European search report - dispatched on: | EP | 14.01.2020 | Classification | IPC: | A61K31/7052, A61K31/7105, A61K38/02, A61K47/55, A61K47/66, A61K35/12, A61K35/30, A61K35/33, A61K35/39, A61K35/407, A61K47/69, C12N5/0793, G01N33/50, C12N5/077, A61K35/34 | [2020/07] | CPC: |
A61K47/6929 (EP,KR,US);
C12N5/0618 (CN);
A61K31/7105 (KR);
A61K35/12 (EP,US);
A61K35/30 (EP,US);
A61K35/33 (EP,US);
A61K35/34 (EP,US);
A61K35/39 (EP,US);
A61K35/407 (EP,US);
A61K47/65 (KR);
A61K47/6923 (EP,KR,US);
A61P43/00 (EP);
C12N5/0619 (EP,KR,US);
C12N5/0654 (KR);
C12N5/0656 (KR);
C12N5/0657 (EP,CN,KR,US);
C12N5/067 (CN,KR);
C12N5/0696 (CN);
C12Q1/025 (US);
G01N33/5044 (EP,KR,US);
C12N2501/60 (EP,CN,US);
C12N2501/65 (EP,CN,US);
C12N2506/1307 (EP,CN,US);
C12N2510/00 (EP,CN,US);
|
| Former IPC [2019/15] | A61K31/7052, A61K31/7105, A61K38/02, A61K47/55, A61K47/66 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/15] | Title | German: | DIREKTE UMPROGRAMMIERUNG EINER MENSCHLICHEN SOMATISCHEN ZELLE AUF EINE AUSGEWÄHLTE (VORBESTIMMTE) DIFFERENZIERTE ZELLE MIT FUNKTIONALISIERTEN NANOPARTIKELN | [2019/15] | English: | DIRECT REPROGRAMMING OF A HUMAN SOMATIC CELL TO A SELECTED (PREDETERMINED) DIFFERENTIATED CELL WITH FUNCTIONALIZED NANOPARTICLES | [2019/15] | French: | REPROGRAMMATION DIRECTE D'UNE CELLULE SOMATIQUE HUMAINE EN CELLULE DIFFÉRENCIÉE (PRÉDÉTERMINÉE) SÉLECTIONNÉE AVEC DES NANOPARTICULES FONCTIONNALISÉES | [2019/15] | Entry into regional phase | 17.12.2018 | National basic fee paid | 17.12.2018 | Search fee paid | 17.12.2018 | Designation fee(s) paid | 17.12.2018 | Examination fee paid | Examination procedure | deleted | Date on which the examining division has become responsible | 17.12.2018 | Examination requested [2019/15] | 10.08.2020 | Amendment by applicant (claims and/or description) | 08.06.2021 | Despatch of a communication from the examining division (Time limit: M06) | 16.12.2021 | Reply to a communication from the examining division | 20.03.2023 | Despatch of a communication from the examining division (Time limit: M06) | 29.09.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 27.06.2019 | Renewal fee patent year 03 | 15.06.2020 | Renewal fee patent year 04 | 14.06.2021 | Renewal fee patent year 05 | 15.06.2022 | Renewal fee patent year 06 | 20.12.2023 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.06.2023 | 07 M06 Fee paid on 20.12.2023 | 30.06.2024 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2013059831 (STEMGENICS INC [US]) [X] 1-4,7,10,11 * examples 1-3; claim all * [I] 5,6,12-15; | [I]US2014087416 (SIMEONOV KAMEN P [US], et al) [I] 1-5,10-15 * paragraph [0129]; example 7 *; | [XI] - YIMIN ZHAO ET AL, "Microarc-oxidized titanium surfaces functionalized with microRNA-21-loaded chitosan/hyaluronic acid nanoparticles promote the osteogenic differentiation of human bone marrow mesenchymal stem cells", INTERNATIONAL JOURNAL OF NANOMEDICINE, (20151027), vol. 2015, no. 10, doi:10.2147/IJN.S94689, pages 6675 - 6687, XP055589035 [X] 1-3,10,12,13,15 * abstract * [I] 4-9,11,14 DOI: http://dx.doi.org/10.2147/IJN.S94689 | [X] - VAIBHAV PANDIT ET AL, "Multilayered Nanoparticles for Gene Delivery Used to Reprogram Human Foreskin Fibroblasts to Neurospheres", TISSUE ENGINEERING. PART C, METHODS DEC 2008, US, (20150801), vol. 21, no. 8, doi:10.1089/ten.tec.2014.0482, ISSN 1937-3384, pages 786 - 794, XP055358654 [X] 1-5,10-13,15 * abstract * DOI: http://dx.doi.org/10.1089/ten.tec.2014.0482 | [X] - XIAO CHEN ET AL, "Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway", BIOMATERIALS., GB, (20150601), vol. 53, doi:10.1016/j.biomaterials.2015.02.071, ISSN 0142-9612, pages 239 - 250, XP055651275 [X] 1-3,10-13,15 * material and methods;; figure 1 * DOI: http://dx.doi.org/10.1016/j.biomaterials.2015.02.071 | [I] - NAOTO MURAOKA ET AL, "Direct Reprogramming of Fibroblasts into Myocytes to Reverse Fibrosis", ANNUAL REVIEW OF PHYSIOLOGY, (20140210), vol. 76, no. 1, doi:10.1146/annurev-physiol-021113-170301, ISSN 0066-4278, pages 21 - 37, XP055138589 [I] 1-4,6,10-15 * material and methods * DOI: http://dx.doi.org/10.1146/annurev-physiol-021113-170301 | [I] - Y.-J. NAM ET AL, "Reprogramming of human fibroblasts toward a cardiac fate", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20130304), vol. 110, no. 14, doi:10.1073/pnas.1301019110, ISSN 0027-8424, pages 5588 - 5593, XP055210948 [I] 1-4,6,10-15 * material and methods;; figure 2 * DOI: http://dx.doi.org/10.1073/pnas.1301019110 | [T] - MIN WEI ET AL, "Nanomaterials modulate stem cell differentiation: biological interaction and underlying mechanisms", JOURNAL OF NANOBIOTECHNOLOGY, (20171025), vol. 15, no. 1, doi:10.1186/s12951-017-0310-5, XP055650869 [T] * the whole document * DOI: http://dx.doi.org/10.1186/s12951-017-0310-5 | International search | [A]US2014315988 (DAHL GARY [US], et al) [A] 1-4, 5/1-4, 6/1-4, 7/1-4, 33-34, 35/33-34* ; entire document *; | [XY]US2014342004 (APRIKYAN ANDRANIK ANDREW [US], et al) [X] 1-4, 5/1-4, 7/1-4, 33-34, 35/33-34 * ; paragraphs [0009]-[0011], [0089]-[0091] * [Y] 6/1-4; | [Y] - ANOKYE-DANSO, F et al., "Highly Efficient miRNA-Mediated Reprogramming of Mouse and Human Somatic Cells to Pluripotency", Cell Stem Cell, (20110408), vol. 8, no. 4, pages 376 - 388, XP028195323 [Y] 6/1-4 * ; abstract; DOI: 10.1016/j.stem.2011.03.001 * DOI: http://dx.doi.org/10.1016/j.stem.2011.03.001 | [Y] - MYOSHI, N et al., "Reprogramming of Mouse and Human Cells to Pluripotency Using Mature MicroRNAs", Cell Stem Cell, (20110603), vol. 8, no. 6, pages 633 - 638, XP028386705 [Y] 6/1-4 * ; abstract; DOI: 10.1016/j.stem.2011.05.001 * DOI: http://dx.doi.org/10.1016/j.stem.2011.05.001 |